Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | |||
---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | |||
Rash | x | x | x | x | ||
Folliculitis | x | x | x | x | ||
Hypertrichosis | x | x | x | x | ||
Miliaria | x | x | x | x | ||
Paraesthesia | x | x | ||||
Pruritus | x | x | x | |||
Telangiectasia | x | x | ||||
Erythema | x | x | x | x | ||
Urticaria | x | |||||
Skin atrophy | x | x | x | x | ||
Dry skin | x | x | x | x | ||
Skin striae | x | x | x | x | ||
Allergic contact dermatitis | x | x | x | x | ||
Leukoderma | x | x | x | x | ||
Acneiform eruption | x | x | x | x | ||
Dermatitis perioral | x | x | x | x | ||
Secondary infection | x | x | x | x | ||
Stinging | x | x | x | x |
Information about indications was extracted from the indications and usage sections of the labels.
Indication | Labels | |||||
---|---|---|---|---|---|---|
Skin disorder | x | x | x | x |
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |